Real-world evidence in oncology: vitally relevant

Over time oncology practice has seen increased complexity of clinically relevant data recorded for patients, and improved methods of recording (including electronic medical records), which has resulted in increasing volumes of real-world data. Utilising this data has the potential to improve cancer care in many ways including:

  • Help to inform clinical decisions in common settings where the current standard of care, or novel single agents or combinations, are employed in multiple patient populations that are poorly represented in the clinical trials leading to regulatory approval.
  • Updating information regarding potential adverse events on a product approved for clinical use based on demonstrated efficacy, but with a limited number of patients treated when initial regulatory permission was granted.

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: FEB2021BS001

Posted in Blogs.